S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

from Lipid Insights · host National Lipid Association

Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science and its implications for clinical practice. Host Peter H. Jones, MD, MNLA sits down with Christie M. Ballantyne, MD, MNLA to discuss the 12-month pivotal trial results from SHASTA-3 and SHASTA-4 — evaluating plozasiran in patients with severe hypertriglyceridemia. If you missed Munich, this is your catch-up.Watch the video version on YouTube HERE.

Episode metadata supplied by the publisher feed · Published Sep 4, 2026

Embed this episode

Attribution link and audio player

Ready to play

S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

0:00 15:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lipid Insights?

This episode is 15 minutes long.

When was this Lipid Insights episode published?

This episode was published on September 4, 2026.

Can I download this Lipid Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!